Walleye Trading’s Avidity Biosciences RNAM Stock Holding History

Walleye Trading’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,500	Closed	-$180K	–	4612
2025 Q4	$180K	Buy	+2,500	New	+$161K	﹤0.01%	3455
2022 Q4	–	Sell	-23,218	Closed	-$379K	–	5345
2022 Q3	$379K	Buy	+23,218	New	+$444K	﹤0.01%	3153

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Walleye Trading's RNAM Position: Q1 2026 in Review

Walleye Trading sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,500 shares — an estimated $180K sold.

Walleye Trading first reported a position in RNAM in Q3 2022 and held it in 2 quarters. The position peaked at $379K in Q3 2022. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Walleye Trading reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 2,500 Avidity Biosciences shares in Q1 2026, an estimated $180K.
Walleye Trading first reported a position in Avidity Biosciences in Q3 2022 and held it in 2 quarters.
Walleye Trading's Avidity Biosciences position peaked at $379K in Q3 2022.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.